FMP
XOMA Corporation
XOMA
NASDAQ
XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
24.32 USD
0.88 (3.62%)
XOMA Financial Statements
Quarter
2024 Q4
2024 Q3
2024 Q2
2024 Q1
Total Revenue
2.34M
7.2M
11.09M
1.49M
Cost of Revenue
0
0
3k
2k
Gross Profit
2.34M
7.2M
11.08M
1.49M
Operating Expenses
9.6M
22.84M
12.16M
8.49M
Research and Development
864k
817k
1.16M
33k
Selling, General & Administrative Expenses
6.99M
8.02M
11M
8.46M
Selling & Marketing Expenses
0
0
-3k
-2k
General & Administrative Expenses
6.99M
8.02M
11M
8.46M
Other Expenses
1.74M
14M
85k
0
Operating Income
-7.25M
-15.64M
-1.08M
-7M
Total Other Income/Expenses Net
-2.37M
-1.6M
26.06M
-1.59M
Income Before Tax
-9.63M
-17.24M
15.98M
-8.6M
Income Tax
-5.66M
0
0
-41.28k
Net Income
-3.97M
-17.24M
15.98M
-8.6M
Basic EPS
-0.46
-1.59
0.88
-0.74
EPS Diluted
-0.46
-1.59
0.84
-0.74
Basic Average Shares
11.85M
11.71M
11.64M
11.58M
Diluted Average Shares
11.85M
11.71M
17.32M
11.58M
EBITDA
-6.02M
-15.64M
-1.08M
-5.04M
Retained Earning Schedule
Quarter
2024 Q4
2024 Q3
2024 Q2
2024 Q1
Retained Earnings (Previous Year)
-1.23B
-1.22B
-1.23B
-1.22B
Net Income
-3.97M
-17.24M
15.98M
-8.6M
Stock Repurchases
0
0
-53k
-13k
Dividend Paid
-1.37M
-1.37M
-1.37M
-1.37M
Retained Earnings
-1.24B
-1.23B
-1.22B
-1.23B
Other Distributions
-5.34M
-18.61M
14.56M
-9.99M
PPE Schedule
Quarter
2024 Q4
2024 Q3
2024 Q2
2024 Q1
Gross PPE
351k
369k
386k
404k
Annual Depreciation
208k
3k
3k
2k
Capital Expenditure
-3k
0
0
-17k
Net PPE
146k
366k
383k
419k
Intangible and Goodwill Schedule
Quarter
2024 Q4
2024 Q3
2024 Q2
2024 Q1
Acquisitions and Adjustments
0
0
0
0
Goodwill (Previous Year)
0
0
0
0
Goodwill
0
0
0
0
All figures are in USD.
